ABBOTT LABORATORIES A/S: Financial statements 2020
CVR: 31528615
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 195,943,716 and a net result of DKK 4,824,760 compared with DKK 6,040,402 the year before. That is an increase of 20.3% compared with the year before. The profit margin was 2.5%. Equity in the 2020 report amounted to DKK 111,714,826. The solvency ratio was 67.9%. The company had 36 employees in the financial year.
- Revenue
- DKK 195,943,716
- Gross Profit
- DKK 39,745,785
- Profit/Loss
- DKK 4,824,760
- Equity
- DKK 111,714,826
- Total Assets
- DKK 164,579,585
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 195.9 mio. | 39.7 mio. | 4.8 mio. | 111.7 mio. | 36 |
| 2019 | 162.9 mio. | 39.8 mio. | 6 mio. | 106.9 mio. | 36 |
| 2018 | 129 mio. | 22.5 mio. | -2.1 mio. | 150.8 mio. | 29 |
| 2017 | 147.4 mio. | 34.4 mio. | 5.7 mio. | 58.9 mio. | 31 |
| 2016 | 134 mio. | 38.8 mio. | 3.3 mio. | 53.2 mio. | - |
Official annual report
How creditworthy is ABBOTT LABORATORIES A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ABBOTT LABORATORIES A/S has published its annual report for 2019. Revenue came to DKK 162,924,491, and the net result was DKK 6,040,402.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.